Applied Health Economics and Health Policy

2008 - 2025

Current editor(s): Timothy Wrightson

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 12, issue 6, 2014

Using Decision Trees to Manage Hospital Readmission Risk for Acute Myocardial Infarction, Heart Failure, and Pneumonia pp. 573-585

John Hilbert, Scott Zasadil, Donna Keyser and Pamela Peele

The MAGEC System for Spinal Lengthening in Children with Scoliosis: A NICE Medical Technology Guidance pp. 587-599

Michelle Jenks, Joyce Craig, Joanne Higgins, Iain Willits, Teresa Barata, Hannah Wood, Christine Kimpton and Andrew Sims

Willingness to Pay for Health Insurance Among HIV-Positive Patients in India pp. 601-610

Indrani Gupta and Mayur Trivedi

Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the UK pp. 611-622

Daniel Gladwell, Thea Henry, Mark Cook and Ron Akehurst

The Importance of Proximity to Death in Modelling Community Medication Expenditures for Older People: Evidence From New Zealand pp. 623-633

Patrick Moore, Kathleen Bennett and Charles Normand

Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland pp. 635-645

Emer Fogarty, Cathal Walsh, Christopher McGuigan, Niall Tubridy and Michael Barry

Cost Utility of Telaprevir–PR (Peginterferon–Ribavirin) Versus Boceprevir–PR and Versus PR Alone in Chronic Hepatitis C in The Netherlands pp. 647-659

Aikaterini Vellopoulou, Michel Agthoven, Annemarie Kolk, Robert Knegt, Gilles Berdeaux, Sandrine Cure, Florence Bianic and Mark Lamotte

Volume 12, issue 5, 2014

Ethical Objections Against Including Life-Extension Costs in Cost-Effectiveness Analysis: A Consistent Approach pp. 471-476

Afschin Gandjour and Dirk Müller

EXOGEN Ultrasound Bone Healing System for Long Bone Fractures with Non-Union or Delayed Healing: A NICE Medical Technology Guidance pp. 477-484

Ailish Higgins, Matthew Glover, Yaling Yang, Susan Bayliss, Catherine Meads and Joanne Lord

E-Vita Open Plus for Treating Complex Aneurysms and Dissections of the Thoracic Aorta: A NICE Medical Technology Guidance pp. 485-495

Muralikrishnan Radhakrishnan, Janet Peacock, Tiago Rua, Rachel Clough, Mercy Ofuya, Yanzhong Wang, Elizabeth Morris, Cornelius Lewis and Stephen Keevil

What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer pp. 497-510

M. Barbieri, H. Weatherly, R. Ara, Hasan Basarir, Mark Sculpher, R. Adams, H. Ahmed, C. Coles, T. Guerrero-Urbano, C. Nutting and M. Powell

Examining the Influence of Antenatal Care Visits and Skilled Delivery on Neonatal Deaths in Ghana pp. 511-522

Monica Lambon-Quayefio and Nkechi Owoo

Diagnostic Needle Arthroscopy and the Economics of Improved Diagnostic Accuracy: A Cost Analysis pp. 523-535

Jeffrey Voigt, Michael Mosier and Bryan Huber

The Impact on Health Outcomes and Healthcare Utilisation of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Lamotrigine in New Zealand pp. 537-546

Charon Lessing, Toni Ashton and Peter Davis

Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases pp. 547-557

Brian Seal, Sean Sullivan, Scott Ramsey, Carl Asche, Ken Shermock, Syam Sarma, Erin Zagadailov, Eileen Farrelly and Michael Eaddy

Comment on: “Insulin Glargine in a Brazilian State: Should the Government Disinvest?” pp. 559-560

Domingos Malerbi

Authors’ Reply to Dr. Malerbi: “Insulin Glargine in a Brazilian State: Should the Government Disinvest?” pp. 561-563

Ana Souza, Francisco de Acurcio, Augusto Guerra Júnior, Renata Nascimento, Brian Godman and Leonardo Diniz

Comment on: “Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers” pp. 565-565

Alessandro Curto and Livio Garattini

Authors’ Reply to Curto and Garattini: “Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers” pp. 567-568

Josh Carlson, Katie Gries, Kai Yeung, Sean Sullivan and Louis Garrison

Volume 12, issue 4, 2014

Are the UK Systems of Innovation and Evaluation of Medical Devices Compatible? The Role of NICE’s Medical Technologies Evaluation Programme (MTEP) pp. 347-357

A. Chapman, C. Taylor and A. Girling

A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder pp. 359-372

Syed Mohiuddin

Economic Evaluations of Guideline-Based or Strategic Interventions for the Prevention or Treatment of Chronic Wounds pp. 373-389

Marissa Carter

Systematic Review of the Cost Effectiveness of Radiation Therapy for Prostate Cancer from 2003 to 2013 pp. 391-408

Neha Amin, David Sher and Andre Konski

Peritoneal Dialysis and In-Centre Haemodialysis: A Cost-Utility Analysis from a UK Payer Perspective pp. 409-420

Catrin Treharne, Frank Liu, Murat Arici, Lydia Crowe and Usman Farooqui

Disease-Specific Impoverishment Impact of Out-of-Pocket Payments for Health Care: Evidence from Rural Bangladesh pp. 421-433

Syed Hamid, Syed Ahsan and Afroza Begum

Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data pp. 435-446

J. Rice, Noam Kirson, Amie Shei, Alice Cummings, Katharine Bodnar, Howard Birnbaum and Rami Ben-Joseph

Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists pp. 447-459

Jenny Willson, Eric Bateman, Ian Pavord, Adam Lloyd, Tania Krivasi and Dirk Esser

The Impact of Rural Health Care Accessibility on Cancer-Related Behaviors and Outcomes pp. 461-470

Eric Belasco, Gordon Gong, Barbara Pence and Ethan Wilkes

Volume 12, issue 3, 2014

Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers pp. 231-238

Josh Carlson, Katharine Gries, Kai Yeung, Sean Sullivan and Louis Garrison

Modelling the Economics of Type 2 Diabetes Mellitus Prevention: A Literature Review of Methods pp. 239-253

Philip Watson, L. Preston, H. Squires, J. Chilcott and A. Brennan

WatchBP Home A for Opportunistically Detecting Atrial Fibrillation During Diagnosis and Monitoring of Hypertension: A NICE Medical Technology Guidance pp. 255-265

Iain Willits, Kim Keltie, Joyce Craig and Andrew Sims

A Systematic Review of Osteoporosis Medication Adherence and Osteoporosis-Related Fracture Costs in Men pp. 267-277

Yeshi Mikyas, Irene Agodoa and Nicole Yurgin

Paying for Formerly Free Medicines in Spain After 1 Year of Co-Payment: Changes in the Number of Dispensed Prescriptions pp. 279-287

Jaume Puig-Junoy, Santiago Rodríguez-Feijoó and Beatriz Lopez-Valcarcel

Modelling Cost Effectiveness in Neovascular Age-Related Macular Degeneration: The Impact of Using Contrast Sensitivity vs. Visual Acuity pp. 289-297

Thomas Butt, Praveen Patel, Adnan Tufail and Gary Rubin

Healthcare Use and Voluntary Health Insurance After Retirement in Thailand pp. 299-313

Papar Kananurak

Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis pp. 315-326

François Bocquet, Pascal Paubel, Isabelle Fusier, Anne-Laure Cordonnier, Claude Pen and Martine Sinègre

Belief Elicitation to Populate Health Economic Models of Medical Diagnostic Devices in Development pp. 327-334

Wieke Haakma, Lotte Steuten, Laura Bojke and Maarten IJzerman

Assessing Medication Adherence and Healthcare Utilization and Cost Patterns Among Hospital-Discharged Patients with Schizoaffective Disorder pp. 335-346

Sudeep Karve, Michael Markowitz, Dong-Jing Fu, Jean-Pierre Lindenmayer, Chi-Chuan Wang, Sean Candrilli and Larry Alphs

Volume 12, issue 2, 2014

Managing Healthcare Budgets in Times of Austerity: The Role of Program Budgeting and Marginal Analysis pp. 95-102

Craig Mitton, Francois Dionne and Cam Donaldson

Systematic Assessment of Decision-Analytic Models for Chronic Myeloid Leukemia pp. 103-115

Ursula Rochau, Ruth Schwarzer, Beate Jahn, Gaby Sroczynski, Martina Kluibenschaedl, Dominik Wolf, Jerald Radich, Diana Brixner, Guenther Gastl and Uwe Siebert

Variation in the Spillover Effects of Illness on Parents, Spouses, and Children of the Chronically Ill pp. 117-124

Tara Lavelle, Eve Wittenberg, Kara Lamarand and Lisa Prosser

A Cross-Sectional Study to Evaluate the Awareness and Attitudes of Physicians Towards Reducing the Cost of Prescription Drugs, Mumbai pp. 125-137

Gauri Billa, Karan Thakkar, Sarita Jaiswar and Dinesh Dhodi

The Impact of Overweight and Obesity on Pediatric Medical Expenditures pp. 139-150

Davene Wright and Lisa Prosser

Cost-Utility Analysis Comparing Heavy-Weight and Light-Weight Mesh in Laparoscopic Surgery for Unilateral Inguinal Hernias pp. 151-163

Dmitrij Achelrod and Tom Stargardt

Firm- and Drug-Specific Patterns of Generic Drug Payments by US Medicaid Programs: 1991–2008 pp. 165-177

Christina Kelton, Lenisa Chang, Jeff Guo, Yan Yu, Edmund Berry, Boyang Bian and Pamela Heaton

Impact of Early Versus Late Systemic Lupus Erythematosus Diagnosis on Clinical and Economic Outcomes pp. 179-190

Alan Oglesby, Caroline Korves, François Laliberté, Gregory Dennis, Sapna Rao, Ellison Suthoff, Robert Wei and Mei Duh

That’s What Friends Are For: Adolescent Peer Social Status, Health-Related Quality of Life and Healthcare Costs pp. 191-201

Marlon Mundt and Larissa Zakletskaia

Economic Evaluation of Using a Genetic Test to Direct Breast Cancer Chemoprevention in White Women with a Previous Breast Biopsy pp. 203-217

Linda Green, Tuan Dinh, David Hinds, Bryan Walser and Richard Allman

Direct Medical Costs for Complications Among Children and Adults with Diabetes in the US Commercial Payer Setting pp. 219-230

Jason Yeaw, Shawn Halinan, Dionne Hines, Amy DeLozier, Magaly Perez, Mark Boye, Kristina Boye and Christopher Blanchette

Volume 12, issue 1, 2014

Remember the MaineRx pp. 1-5

Robert Kemp

Propensity-Score Matching in Economic Analyses: Comparison with Regression Models, Instrumental Variables, Residual Inclusion, Differences-in-Differences, and Decomposition Methods pp. 7-18

William Crown

Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review pp. 19-32

Ana Caires de Souza, Francisco de Acurcio, Augusto Guerra Júnior, Renata Rezende Macedo do Nascimento, Brian Godman and Leonardo Diniz

A Critical Systematic Review of Budget Impact Analyses on Drugs in the EU Countries pp. 33-40

Katelijne Vooren, Silvy Duranti, Alessandro Curto and Livio Garattini

The Cost Effectiveness of Implantable Cardioverter Defibrillators: A Systematic Review of Economic Evaluations pp. 41-49

Fotini Gialama, Panagiotis Prezerakos and Nikos Maniadakis

Cost-Effectiveness Analysis of Clinically Indicated Versus Routine Replacement of Peripheral Intravenous Catheters pp. 51-58

Haitham Tuffaha, Claire Rickard, Joan Webster, Nicole Marsh, Louisa Gordon, Marianne Wallis and Paul Scuffham

Economic Burden and Disparities in Healthcare Resource Use Among Adult Patients with Cardiac Arrhythmia pp. 59-71

Derek Tang, Adrienne Gilligan and Klaus Romero

How Important Is Health Status in Defining Quality of Life for Older People? An Exploratory Study of the Views of Older South Australians pp. 73-84

Catherine Milte, Ruth Walker, Mary Luszcz, Emily Lancsar, Billingsley Kaambwa and Julie Ratcliffe

Budget Impact Analysis of Liposomal Amphotericin B and Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections in the United States pp. 85-93

Hongbo Yang, Paresh Chaudhari, Zheng-Yi Zhou, Eric Wu, Chad Patel and David Horn